Related references
Note: Only part of the references are listed.Serum soluble Klotho is inversely related to coronary artery calcification assessed by intravascular ultrasound in patients with stable coronary artery disease
Seiji Koga et al.
JOURNAL OF CARDIOLOGY (2021)
Count Data in Medical Research: Poisson Regression and Negative Binomial Regression
Patrick Schober et al.
ANESTHESIA AND ANALGESIA (2021)
Pathophysiological Implications of Imbalances in Fibroblast Growth Factor 23 in the Development of Diabetes
Javier Donate-Correa et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
Robert Ross et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
Peter Willeit et al.
CIRCULATION (2020)
Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics
Martin H. Sorensen et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
Stanley M. H. Yeung et al.
CURRENT DIABETES REPORTS (2020)
Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research
Meiheng Sun et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The Protective Role of Klotho in CKD-Associated Cardiovascular Disease
Xianjin Bi et al.
KIDNEY DISEASES (2020)
Serum klotho is inversely associated with metabolic syndrome in chronic kidney disease: results from the KNOW-CKD study
Hyo Jin Kim et al.
BMC NEPHROLOGY (2019)
Ultrasound Tissue Characterization of Carotid Plaques Differs Between Patients with Type 1 Diabetes and Subjects without Diabetes
Esmeralda Castelblanco et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function
Stanley M. H. Yeung et al.
DIABETES CARE (2019)
The Klotho proteins in health and disease
Makoto Kuro-o
NATURE REVIEWS NEPHROLOGY (2019)
Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk
Alexander E. Berezin et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients
Heng-Chih Pan et al.
ATHEROSCLEROSIS (2018)
Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes
Marc Carbonell et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation
Xiang Hu et al.
CLINICAL NUTRITION (2018)
Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease
Xiang Lu et al.
KIDNEY DISEASES (2017)
Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes
Emilie H. Zobel et al.
DIABETES CARE (2017)
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease
Jose Tunon et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2016)
Is serum Klotho protective against atherosclerosis in patients with type 1 diabetes mellitus?
Nursen Keles et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness
Gemma Llaurado et al.
PLOS ONE (2015)
Low Serum Level of Klotho Is an Early Predictor of Atherosclerosis
Nursen Keles et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Building Bivariate Tables: ThecompareGroupsPackage forR
Isaac Subirana et al.
Journal of Statistical Software (2015)
Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) study
Aaron R. Folsom et al.
AMERICAN HEART JOURNAL (2014)
Fibroblast growth factor 23 and Klotho serum levels in healthy children
Despoina Gkentzi et al.
BONE (2014)
Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
Sarah Seiler et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Reduced Klotho is associated with the presence and severity of coronary artery disease
Juan F. Navarro-Gonzalez et al.
HEART (2014)
Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays
Lise Pedersen et al.
CLINICAL BIOCHEMISTRY (2013)
Reproducibility and validity of a food frequency questionnaire among pregnant women in a Mediterranean area
Jesus Vioque et al.
NUTRITION JOURNAL (2013)
A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
Masashi Kitagawa et al.
PLOS ONE (2013)
Statin Upregulates the Expression of Klotho, an Anti-Aging Gene, in Experimental Cyclosporine Nephropathy
Hye Eun Yoon et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2012)
Vitamin D Deficiency and Coronary Artery Calcification in Subjects With Type 1 Diabetes
Kendra A. Young et al.
DIABETES CARE (2011)
Vitamin D Levels, Microvascular Complications, and Mortality in Type 1 Diabetes
Christel Joergensen et al.
DIABETES CARE (2011)
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
Michael F. Holick et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Plasma Klotho and Cardiovascular Disease in Adults
Richard D. Semba et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy
Hye Eun Yoon et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Share Paper
